241 related articles for article (PubMed ID: 35167663)
1. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias.
Song Y; Bi X; Chen L; Yang K; Chen X; Dong Z; Wang J; Kong X; Zhao K; Wang H; Duru F; Lu M; Ma L; Qiao S; Zhao S
Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1006-1015. PubMed ID: 35167663
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
Almaas VM; Haugaa KH; Strøm EH; Scott H; Smith HJ; Dahl CP; Geiran OR; Endresen K; Aakhus S; Amlie JP; Edvardsen T
Heart; 2014 Apr; 100(8):631-8. PubMed ID: 24368281
[TBL] [Abstract][Full Text] [Related]
3. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
4. Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction.
Zhong Y; Li C; Yu Y; Du Y; Bai Y; Wang X; Dai X; Fan G; Wang G
Int J Cardiovasc Imaging; 2024 Apr; 40(4):921-930. PubMed ID: 38448705
[TBL] [Abstract][Full Text] [Related]
5. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
6. Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: Differences in Global and Segmental Myocardial Strain by Cardiac Magnetic Resonance Feature Tracking.
Palmisano V; Cossa S; Esposito A; Bassareo PP; Porcu M; Cau R; Pontone G; Suri JS; Saba L
J Thorac Imaging; 2022 Jan; 37(1):49-57. PubMed ID: 34387228
[TBL] [Abstract][Full Text] [Related]
7. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study.
Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
BMC Cardiovasc Disord; 2020 Jun; 20(1):298. PubMed ID: 32552709
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
[TBL] [Abstract][Full Text] [Related]
9. Incremental value of myocardial global longitudinal strain in predicting major adverse cardiac events among patients with hypertrophic cardiomyopathy.
Zhuang H; Yang K; Zhao S; Wu J; Xu N; Zhang L; Qi X; Zhang M; Song L; Pang K
Echocardiography; 2024 May; 41(5):e15834. PubMed ID: 38784981
[TBL] [Abstract][Full Text] [Related]
10. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with late gadolinium enhancement on cardiac magnetic resonance.
Polaková E; Liebregts M; Marková N; Adla T; Kara B; Ten Berg J; Bonaventura J; Veselka J
Int J Cardiol; 2020 Nov; 319():101-105. PubMed ID: 32682963
[TBL] [Abstract][Full Text] [Related]
13. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of myocardial activity at
Zhang Y; Dong Z; Wang L; Wang YL; Chen BX; Su Y; Zhao S; Yang MF
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):110-122. PubMed ID: 37642705
[TBL] [Abstract][Full Text] [Related]
15. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.
Wabich E; Dorniak K; Zienciuk-Krajka A; Nowak R; Raczak G; Daniłowicz-Szymanowicz L
J Cardiol; 2021 May; 77(5):475-481. PubMed ID: 33246844
[TBL] [Abstract][Full Text] [Related]
16. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
Zhi Y; Gui FD; Xue M; Long YT; Miao W; Yi Y; Gao LC; Bing F; Pan SY
BMC Cardiovasc Disord; 2024 Apr; 24(1):203. PubMed ID: 38594610
[TBL] [Abstract][Full Text] [Related]
17. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
18. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
[TBL] [Abstract][Full Text] [Related]
19. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
[TBL] [Abstract][Full Text] [Related]
20. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
